Stephen D. Steinour
Known title: Chairman & CEOCIK: 0001213991
Stephen D. Steinour's purchase track record
How the stock did after each of Stephen D. Steinour's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since April 26, 2022
Stock higher 6 months later
100%
3 months: 67%
Median 6-month return
+11.9%
3 months: +12.3%
Beat the S&P 500
67%
median +7.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/12/2026 | HBAN | $500K | +12.3% | +10.2% | +13.8% |
| 11/21/2025 | BBWI | $100K | +65.5% | +20.6% | +13.2% |
| 4/26/2022 | HBAN | $199K | -3.9% | +11.9% | -7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BBWI shares jump 8.7% amid product innovation news. Bath & Body Works stock rose 8.7% recently, a move linked to its push into sensitive-skin products and broader product innovation. This strategy aims to support pricing as consumers look for value. The company also has a low P/E ratio of 4.5, which some analysts view as undervalued, though questions remain about its long-term outlook.
Transaction History
| HBAN | ▲ Buy | Grant | 7,250 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 591 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 6,030 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 483 | $0 | 7/1/2026 | View on chart |
| BBWI | ▲ Buy | Grant | 7,970 | $0 | 6/11/2026 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 25,313 | $255K | 4/29/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 19,934 | $325K | 4/29/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 6,810 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 542 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Open Market | 32,277 | $500K | 3/12/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 433,724 | $0 | 3/9/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 193,441 | $3.1M | 3/9/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 193,753 | $0 | 3/2/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 21,393 | $359K | 2/27/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 45,066 | $757K | 2/27/2026 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 250,000 | $2.5M | 2/6/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 64,512 | $1.2M | 2/6/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 115,902 | $2.2M | 2/6/2026 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 50,000 | $503K | 2/4/2026 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 33,726 | $645K | 2/4/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 6,223 | $0 | 1/2/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 492 | $0 | 1/2/2026 | View on chart |
| HBAN | ▼ Sell | Gift | 180,000 | $0 | 12/8/2025 | View on chart |
| BBWI | ▲ Buy | Open Market | 6,700 | $100K | 11/21/2025 | View on chart |
| HBAN | ▼ Sell | Gift | 64,000 | $0 | 11/19/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 491 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 6,327 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 6,219 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 495 | $0 | 7/1/2025 | View on chart |
| BBWI | ▲ Buy | Grant | 5,641 | $0 | 6/5/2025 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 34,055 | $371K | 4/28/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 29,427 | $427K | 4/28/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 29,370 | $426K | 4/24/2025 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 34,000 | $370K | 4/24/2025 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 100,000 | $1.1M | 4/22/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 87,395 | $1.2M | 4/22/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 7,476 | $0 | 4/1/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 183 | $3K | 4/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 558 | $0 | 4/1/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 17,615 | $269K | 3/26/2025 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 100,000 | $1.1M | 3/14/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 85,891 | $1.3M | 3/14/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 437,057 | $0 | 3/7/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 198,206 | $3.0M | 3/7/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 170,475 | $0 | 3/3/2025 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 20,910 | $344K | 2/28/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 495 | $0 | 1/2/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 6,144 | $0 | 1/2/2025 | View on chart |
| HBAN | ▼ Sell | Gift | 57,000 | $0 | 12/20/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 558 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 6,894 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 1,002 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 7,414 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 1,298 | $0 | 7/1/2024 | View on chart |
| BBWI | ▲ Buy | Grant | 3,844 | $0 | 6/27/2024 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 28,981 | $396K | 5/1/2024 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 154,821 | $2.0M | 4/16/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 341,391 | $0 | 4/16/2024 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 16,870 | $225K | 3/26/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 208,494 | $0 | 3/1/2024 | View on chart |
| BBWI | ▲ Buy | Grant | 3,572 | $0 | 6/8/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 126,347 | $1.4M | 5/1/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 600,216 | $0 | 5/1/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 17,020 | $187K | 5/1/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 25,994 | $286K | 5/1/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 176,470 | $0 | 3/1/2023 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 9,940 | $100K | 8/1/2022 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 9,182 | $100K | 8/1/2022 | View on chart |
| BBWI | ▲ Buy | Grant | 3,091 | $0 | 5/12/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 311,857 | $0 | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 18,411 | $242K | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 27,756 | $365K | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 17,143 | $225K | 5/1/2022 | View on chart |
| HBAN | ▲ Buy | Open Market | 14,234 | $199K | 4/26/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 171,994 | $0 | 3/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 4,551 | $71K | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted
Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.